Is cD98 expression associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases?
In our limited series, CD98 is a pathological factor that predicts prognosis in resectable adenocarcinoma patients with N2 disease.
In vitro screening of different AOs within the same chemical class is a reliable method for predicting the in vivo exon skipping efficiency of AOs for DMD.